These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30809892)

  • 1. Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake.
    Takenoshita S; Terada S; Oshima E; Yamaguchi M; Hayashi S; Hinotsu K; Esumi S; Shinya T; Yamada N
    Psychogeriatrics; 2019 Nov; 19(6):566-573. PubMed ID: 30809892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
    Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
    Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy.
    Kobayashi K; Sumiya H; Nakano H; Akiyama N; Urata K; Koshino Y
    Int J Geriatr Psychiatry; 2010 Jan; 25(1):55-65. PubMed ID: 19637401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].
    Marquié Sayagués M; Da Silva Alves L; Molina-Porcel L; Alcolea Rodríguez D; Sala Matavera I; Sánchez-Saudinós MB; Camacho Martí V; Estorch Cabrera M; Blesa González R; Blesa González R; Gómez-Isla T; Gómez-Isla T; Lleó Bisa A; Lleó Bisa A
    Neurologia; 2010 Sep; 25(7):414-21. PubMed ID: 20964987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study.
    Kobayashi K; Nakano H; Akiyama N; Maeda T; Yamamori S
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):663-8. PubMed ID: 25335897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autopsy Validation of the Diagnostic Accuracy of
    Matsubara T; Kameyama M; Tanaka N; Sengoku R; Orita M; Furuta K; Iwata A; Arai T; Maruyama H; Saito Y; Murayama S
    Neurology; 2022 Apr; 98(16):e1648-e1659. PubMed ID: 35256483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
    Novellino F; Bagnato A; Salsone M; Cascini GL; Nicoletti G; Arabia G; Pugliese P; Morelli M; Paglionico S; Cipullo S; Manna I; De Marco EV; Condino F; Chiriaco C; Morgante L; Zappia M; Quattrone A
    Neurobiol Aging; 2010 Nov; 31(11):1903-11. PubMed ID: 19135762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies.
    Kobayashi S; Tateno M; Morii H; Utsumi K; Saito T
    Psychiatry Res; 2009 Oct; 174(1):76-80. PubMed ID: 19766460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
    King AE; Mintz J; Royall DR
    Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
    Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
    Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
    Manabe Y; Inui Y; Toyama H; Kosaka K
    Psychiatry Res Neuroimaging; 2017 Mar; 261():75-79. PubMed ID: 28152401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
    Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
    Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
    Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
    Yoshita M; Taki J; Yamada M
    J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease.
    Takahashi M; Ikemura M; Oka T; Uchihara T; Wakabayashi K; Kakita A; Takahashi H; Yoshida M; Toru S; Kobayashi T; Orimo S
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):939-44. PubMed ID: 25935891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases.
    Nakae I; Hayashi H; Mitsunami K; Horie M
    Ann Nucl Med; 2013 Oct; 27(8):737-47. PubMed ID: 23728513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.